Part,  Chapter, Paragraph

  1   II,     5.  1.  1|            incident patients.~Food Allergy~In adults, main foods responsible
  2   II,     5.  1.  1|           with an increase of food allergy because of the incomplete
  3   II,     5.  1.  1|           higher incidence of food allergy, because of the loss of
  4   II,     5.  8.  3|         past year, namely: asthma, allergy, osteoporosis, hypertension,
  5   II,     5.  9.Acr|        Health Survey~GA LEN~Global Allergy and Asthma European Network~
  6   II,     5.  9.Acr|            Adults~MAS~Multicentric Allergy Study~PASTURE~Protection
  7   II,     5.  9. FB|            FB.1. Introduction~ ~An allergy is an exaggerated reaction
  8   II,     5.  9. FB|        several organs and tissues. Allergy has developed into a major
  9   II,     5.  9. FB|           affected by some form of allergy and two-thirds of them stating
 10   II,     5.  9. FB|    two-thirds of them stating that allergy presents a serious handicap
 11   II,     5.  9. FB|         EFA-European Federation of Allergy and Airways Diseases Patients~
 12   II,     5.  9. FB|        Clustering of European food allergy research~- World Allergy
 13   II,     5.  9. FB|           allergy research~- World Allergy Organization~ ~
 14   II,     5.  9. FB|                       5.FB.3. The “allergy march”~ ~This disease often
 15   II,     5.  9. FB|          This evolution, known as “allergy march”, needs to be carefully
 16   II,     5.  9. FB|          from at least one form of allergy. Furthermore, allergic diseases
 17   II,     5.  9. FB|           is affected by a form of allergy. The problem of diagnosis
 18   II,     5.  9. FB|      lifestyles throughout Europe, allergy prevalence among teenagers
 19   II,     5.  9. FB|           more prone to develop an allergy, but this gap is balanced
 20   II,     5.  9. FB|           to suffer from a form of allergy. Significant higher prevalence
 21   II,     5.  9. FB|        association of obesity with allergy or atopy and its meaning
 22   II,     5.  9. FB|       atopic eczema or respiratory allergy. A recent, large randomized
 23   II,     5.  9. FB|             to prevent respiratory allergy; treat upper airways disease (
 24   II,     5.  9. FB|        obesity and asthma. Current allergy and asthma reports 2007,
 25   II,     5.  9.  2|    Research;~- The GA²LEN - Global Allergy and Asthma European Network
 26   II,     5.  9.  2| cross-sectional study by the World Allergy Organization (WAO), including
 27   II,     5.  9.  3|           of the May 2007 issue of Allergy (Mantovani et al, 2007),
 28   II,     5.  9.  3|         According to the “European Allergy White Paper” (Allergic diseases
 29   II,     5.  9.  3|       Europe, The UCB Institute of Allergy, 1997), health care providers
 30   II,     5.  9.  4|            determine and aggravate allergy and asthma-related symptoms.
 31   II,     5.  9.  4|           Swiss Study on Childhood Allergy and Respiratory Symptoms
 32   II,     5.  9.  4|            MAS study, Multicentric Allergy Study). For cat epithelium,
 33   II,     5.  9.  4|           underwent skin tests for allergy to nine common aeroallergens (
 34   II,     5.  9.  4|            8357 subjects, complete allergy skin and in-vitro tests
 35   II,     5.  9.  4|           prevalence of asthma and allergy does not correlate precisely
 36   II,     5.  9.  4|         and on adjuvant potency in allergy animal models. Coarse (2.
 37   II,     5.  9.  4|        parameters in the different allergy models and between allergy
 38   II,     5.  9.  4|         allergy models and between allergy and inflammation markers
 39   II,     5.  9.  4|           activity for respiratory allergy, whereas clusters of crustal
 40   II,     5.  9.  4|   exclusive associated to systemic allergy. The present study showed
 41   II,     5.  9.  4|         assay for the screening of allergy adjuvant activity since
 42   II,     5.  9.  4|       disease burden in asthma and allergy, and points to fine and
 43   II,     5.  9.  4|        tend to have high levels of allergy triggers, such as dust mites,
 44   II,     5.  9.  5|     research capacity in Europe on Allergy and Asthma issues coordinated
 45   II,     5.  9.  5|          to decrease the burden of allergy and asthma throughout Europe.~ ~
 46   II,     5.  9.  5|          development of asthma and allergy and to assess the reasons
 47   II,     5.  9.  5|           Respiratory Medicine) or Allergy Units run by specialists (
 48   II,     5.  9.  5|         specialists (Pneumology or Allergy and some by both). At the
 49   II,     5.  9.  7|   lifestyle -- the PARSIFAL study. Allergy. 2006 Apr;61(4):414-21.~ ~
 50   II,     5.  9.  7|            on quality of life. Ann Allergy Asthma Immunol. 2006; 97:
 51   II,     5.  9.  7|    Allergies in Childhood. Pediatr Allergy Immunol. 2007 Jul 25; [Epub
 52   II,     5.  9.  7|             2007a): Nu I. Clin Exp Allergy 37:780-7.~ ~Bousquet PJ,
 53   II,     5.  9.  7|            Jarvis D (2007b): Ge I. Allergy 62:301-9.~ ~Braido F, Baiardini
 54   II,     5.  9.  7|          Clinical and Experimental Allergy, 37, 788–79~ ~Bugiani M (
 55   II,     5.  9.  7|          of young adults in Italy. Allergy 2005, 60:165-170~ ~Burney
 56   II,     5.  9.  7|      Henley K, Canonica GW (2007): Allergy prevalence survey by the
 57   II,     5.  9.  7|     prevalence survey by the World Allergy Organization. Allergy Clin
 58   II,     5.  9.  7|        World Allergy Organization. Allergy Clin Immunol IntJ World
 59   II,     5.  9.  7|         Clin Immunol IntJ World Allergy Org; 19:82-90.~ ~Custovic
 60   II,     5.  9.  7|    inhalant allergens in adults. J Allergy Clin Immunol. 2003 Feb;111(
 61   II,     5.  9.  7|      history of asthma in Italy. J Allergy Clin Immunol. 2002 Aug;110(
 62   II,     5.  9.  7|    population-based study. Pediatr Allergy Immunol. 2007 May;18(3):
 63   II,     5.  9.  7|      design - a GA2LEN initiative. Allergy 2006;61:221-228~ ~Kim DS,
 64   II,     5.  9.  7|    Drake-Lee AB (2003). Infection, allergy and the hygiene hypothesis:
 65   II,     5.  9.  7|          of general practitioners. Allergy. May;62(5):569-71)~ ~Migliore
 66   II,     5.  9.  7|         results of SIDRIA-2 study. Allergy 2007; 62:293-300~ ~Osman
 67   II,     5.  9.  7|       allergic sensitization. Curr Allergy Asthma Rep. 2005 May; 5(
 68   II,     5.  9.  7|        detection, and diagnosis. J Allergy Clin Immunol. 2001 Jul;108(
 69   II,     5.  9.  7|           8~ ~The UCB Institute of Allergy (1997): Allergic diseases
 70   II,     5.  9.  7|          1997~ ~Ventura MT (2004): Allergy, asthma and markers of infections
 71   II,     5.  9.  7|        migrants to Southern Italy. Allergy 2004; 59:632-636~ ~Verlato
 72   II,     5.  9.  7|     Results of an Italian study. J Allergy Clin Immunol. 2003 Jun;111(
 73   II,     5.  9.  7|       factors for atopy in Europe. Allergy 2006;61:407-413~ ~Vrbica
 74   II,     5.  9.  7|          environmental antigens. J Allergy Clin Immunol. 2006 Jul;118(
 75   II,     5. 10    |                         5.10. Food allergy and intolerance~ ~
 76   II,     5. 10.Acr|          EU~European Union~FA~Food Allergy~FHS~Food Hypersensitivity~
 77   II,     5. 10.  1|           mediated reactions (food allergy) involving either the synthesis
 78   II,     5. 10.  1|          clinically confirmed food allergy (FA), which has been roughly
 79   II,     5. 10.  1|          case of IgE-mediated food allergy, where very small amounts
 80   II,     5. 10.  2|    AllerPredict~http n/~Asthma and Allergy~http de~Bioinformatics for
 81   II,     5. 10.  2|      studying the problems of food allergy, with funding from the European
 82   II,     5. 10.  2|       scientific name, occurrence, allergy information (cross-reactivity,
 83   II,     5. 10.  2|          hypersensitivity and food allergy~ ~The first attempt to collect
 84   II,     5. 10.  2|         specific reference to food allergy, apart from dermatitis due
 85   II,     5. 10.  2|         Angioneurotic oedema~995.3~Allergy, unspecified~E865~Accidental
 86   II,     5. 10.  2|         Angioneurotic oedema~T78.4~Allergy, unspecified~Source: EU
 87   II,     5. 10.  3|       Figure 5.10.2. Reported food allergy/intolerance prevalence rates
 88   II,     5. 10.  3|    Prevalence of IgE-mediated food allergy~ ~There is a wide difference
 89   II,     5. 10.  3|           of non IgE-mediated food allergy~Celiac disease (also known
 90   II,     5. 10.  3|     diffused non IgE-mediated food allergy worldwide (Figure 5.10.3),
 91   II,     5. 10.  5|          main way of managing food allergy and intolerance is avoiding
 92   II,     5. 10.  5|          and non IgE-mediated food allergy, or between food allergy
 93   II,     5. 10.  5|           allergy, or between food allergy and food intolerance regarding
 94   II,     5. 10.  7|           2007): IgE-Mediated food allergy diagnosis: Current status
 95   II,     5. 10.  7|         2003): Allergen databases. Allergy 58(11):1093-1100.~ ~de Blok
 96   II,     5. 10.  7|          the social impact of food allergy across Europe: a EuroPrevall
 97   II,     5. 10.  7|            state of the art paper. Allergy 62, 733–737.~ ~DunnGalvin
 98   II,     5. 10.  7|           gender dimension in food allergy research: a review. Allergy
 99   II,     5. 10.  7|        allergy research: a review. Allergy 61,1336-1343.~ ~European
100   II,     5. 10.  7|     concise monograph series: food allergy. Brussels: International
101   II,     5. 10.  7|        pylori infections. Clin Exp Allergy 32: 373-378.~Løvik M and
102   II,     5. 10.  7|           food allergen labelling? Allergy 59:1262-8.~ ~Mills ENC,
103   II,     5. 10.  7|             cost and basis of food allergy across Europe. Allergy 62 (
104   II,     5. 10.  7|        food allergy across Europe. Allergy 62 (7), 717–722.~ ~Rona
105   II,     5. 10.  7|             The prevalence of food allergy: A meta-analysis. J Allergy
106   II,     5. 10.  7|        allergy: A meta-analysis. J Allergy Clin Immunol 120, 638-646.~ ~
107   II,     5. 10.  7|           increasing prevalence of allergy: is atopy a microbial deprivation
108   II,     5. 10.  7|    microbial deprivation disorder? Allergy 56: 91-102.~Tay L (2006):
109   II,     5. 10.  7|   reactions overestimate true food allergy in the community. Eur J
110   II,     5. 11.  3|    angio-edema, bee and wasp venom allergy, drug rashes such as the
111   II,     5. 11.  3|       concern about the associated allergy risk.~ ~Most body piercing
112   II,     5. 11.  3|           Belsito, 1999).~ ~Nickel allergy is the most common and has
113   II,     5. 11.  3|            2001). Moreover, nickel allergy can be so severe as to induce
114   II,     5. 11.  3|           the prevalence of nickel allergy among young females with
115   II,     5. 11.  3|           Fisher, 1991).~ ~Once an allergy to nickel has been acquired,
116   II,     5. 11.  3|           of 44 (4.6%) had contact allergy to both nickel and cobalt,
117   II,     5. 11.  3|       whereas 7 (0.7%) had contact allergy to cobalt (B Larsson-Stymne
118   II,     5. 11.  3|        1997). In Portugal, contact allergy to gold sodium thiosulfate (
119   II,     5. 11.  3|        children aged 018 , nickel allergy decreased significantly
120   II,     5. 11.  3|           8% and 21.9 % for nickel allergy, thus testifying that the
121   II,     5. 11.  3|   testifying that the frequency of allergy had remained at the same
122   II,     5. 11.  3|            Dotterud, E Falk, Metal allergy in north Norwegian schoolchildren
123   II,     5. 11.  3|         piercing–a cause of nickel allergy in schoolgirls?, Contact
124   II,     5. 11.  3|               Prevalence of nickel allergy among Finnish university
125   II,     5. 11.  3|           Uter, Decrease in nickel allergy in Germany and regulatory
126   II,     5. 11.  3|                  M Pece o, Contact allergy to gold sodium thiosulfate.
127   II,     5. 11.  3|            school girls had nickel allergy, with the highest rates
128   II,     5. 11.  7|       piercing – a cause of nickel allergy in schoolgirls. Contact
129  III,    10.  3.  2|           people with known nickel allergy because of potential cross-reactions.~ ~
130  III,    10.  5.  1|      significant factors. Clin Exp Allergy 35:126-136.~ ~Vandentorren
131  III,    10.  5.  1|          in Taiyuan, China Pediatr Allergy Immunol 2008.~ ~ ~
132  Key,   Ap5.  0.  0|  allergenicity~allergens~allergies~allergy~allograft~alopecia~alzheimer~